Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

OpiAID LLC
Profile last edited on: 4/7/21      CAGE: 88A03      UEI: GLP5YD2PDSG4

Business Identifier: Detecting biological indicators of overdose
Year Founded
2018
First Award
2020
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1844 Sir Tyler Drive
Wilmington, NC 28405
   (910) 594-4862
   N/A
   www.opiaid.tech
Location: Single
Congr. District: 07
County: New Hanover

Public Profile

OpiAID is structured around development of an advanced wearable device designed to aid in treatment for opioid abuse - effectively enabling more effective prevention and treatment through Technology Asisted Therapy. The device works by detecting biological indicators of overdose, withdrawal, and relapse.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$276,533
Phase II Dollars
$55,000
Total Awarded
$331,533

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $331,533
Project Title: Development of the Strength Band Platform, a Technology Assisted Therapy Platform to Aid with Opioid Abuse Treatment.
0 1 NIH $319,589
Project Title: Development of the OpiAID strength band platform

Key People / Management

  David Reeser -- Founder and CEO

  Tyler Sugden -- Chief Operating Officer

Company News

There are no news available.